NetworkNewsBreaks Archive - Page 1590 of 2224

WednesdayJan 29, 2020 11:53 am

NetworkNewsBreaks – Inovio Pharmaceuticals, Inc. (NASDAQ: INO) to Host Expert Call on Coronavirus Implications Both Near its Source and Closer to Home

Inovio Pharmaceuticals (NASDAQ: INO) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. According to the update, the company intends to host a conference call at 10:30 a.m. EST on Monday, February 3, 2020, during which Dr. David B. Weiner, Ph.D. will discuss implications of the coronavirus epidemic both near its source and closer to home, given the recent outbreak of a new strain in China and its spread to North America. Dr Weiner is executive vice president of the Wistar Institute, director of Vaccine & Immunotherapy Center, and professor emeritus at the University of…

WednesdayJan 29, 2020 11:25 am

NetworkNewsBreaks – QuickLogic Corp (NASDAQ: QUIK) Featured as “Differentiated Sensor Processing and AI Platform Investment Opportunity” in Roth Equity Research Report

QuickLogic Corp (NASDAQ: QUIK) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. The report reads, “We believe QUIK represents a differentiated sensor processing and AI platform investment opportunity. We are encouraged by QUIK’s decision to reduce its workforce by nearly one-third. QUIK also provided preliminary reaffirmation of its prior 4Q19 guidance for revenue. We now expect ‘20e growth to results in a closer break-even than prior to the restructuring announcement. We lower our price target from $8.50 to $6.50 and maintain to Neutral.” To view the full report, visit http://nnw.fm/I5t1N About QuickLogic Corp QuickLogic…

WednesdayJan 29, 2020 10:51 am

NetworkNewsBreaks – Sugarmade, Inc. (SGMD) Announces New, Bold Shift in Business Strategy, Eyes On-Demand Revolution of the Cannabis Sector

Sugarmade (OTCQB: SGMD) today announced a new and bold shift in its business strategy toward the virtualization of the cannabis sector as part of the major shift in the U.S. business model toward an on-demand economy. According to the update, Sugarmade will make several strategic moves over the coming weeks as it launches on-demand and related business operations via internally developed initiatives and new relationships with proven sector business operators. “Things are changing in society and in the economy as virtualization proliferates. Many of the most dynamic and innovative growth companies are part of this on-demand revolution and it is…

WednesdayJan 29, 2020 10:15 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Independent Research Findings on TUSC2 as a Potential Target and Biomarker for Thyroid Carcinoma

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that, in a recent study, independent researchers reported that TUSC2, a tumor suppressor gene and the active agent in Genprex’s Oncoprex(TM) immunogene therapy, is a potential target and biomarker for thyroid carcinoma. Genprex has no affiliation with these researchers. The study, published in the International Journal of Molecular Sciences, reports that TUSC2 overexpression decreased thyroid cancer proliferation, migration and invasion. “We continue to be encouraged by data resulting from studies conducted at multiple research institutions…

WednesdayJan 29, 2020 9:48 am

NetworkNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Closes Deal to Purchase Hemp Extraction Company Kase Farma Inc.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), a hemp-biomass processing entity, this morning announced the closing of its previously announced share and purchase agreement (“SPA”) with Starling Brands, Inc., a party at arm's length to HTC, pursuant to which HTC purchased all the issued and outstanding shares of Kase Farma Inc. Kase Farma, which is authorized to operate in the areas of hemp cultivation, extraction, refining and formulation in the State of California, is now a wholly owned subsidiary of HTC. In accordance with the agreement, the company retains the management services of Starling, led by highly regarded experts in…

WednesdayJan 29, 2020 9:30 am

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) CEO Enters Voluntary Escrow Agreement; Plans to Hold Shares for Minimum of 12 Months

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) this morning announced that CEO and largest shareholder Kelly Jennings is entering into a voluntary escrow agreement with Computershare and reported that he will not sell his shares for at least 12 months, until January 29, 2021. This commitment is additional to any escrow imposed by the TSX Venture Exchange. Jennings holds 41,865,283 shares of PowerBand, representing about 37% of the company's outstanding shares. “I want people to know I am invested in PowerBand for the long run as we revolutionize how cars and trucks are bought, sold, leased and auctioned,” PowerBand…

TuesdayJan 28, 2020 2:00 pm

NetworkNewsBreaks – TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) Announces Changes to Executive Leadership Team

Global cannabis company TerrAscend (CSE: TER) (OTCQX: TRSSF) this morning announced that it has made modifications to its leadership team in coordination with the company’s focus on its rapidly scaling U.S. retail, manufacturing, and distribution operations. Michael Nashat has stepped down as CEO but will continue to serve as a member of the Board of Directors and act as a strategic advisor to the company. Jason Ackerman, executive chairman of the company, has been named interim CEO. “While it was a difficult decision, I believe given TerrAscend's premier operating assets in the United States, it is now time for me…

TuesdayJan 28, 2020 1:19 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Leverages Unique Competitive Advantage

Predictive Oncology (NASDAQ: POAI), a data and artificial-intelligence- (“AI”) driven, discovery-services company, possesses a unique advantage over its competition in the form of samples and access to historical data on clinical outcomes. This data could enable POAI to produce value to pharmaceutical companies significantly faster than its competitors. An article discussing the company reads, “Specifically, POAI can leverage two unique proprietary assets, from its acquisition of Helomics, which virtually eliminate development risk, a factor that considerably weighs on competitors’ efforts in the precision medicine space. First, Predictive Oncology possesses a clinically validated, tumor-profiling platform built from data derived from actual…

TuesdayJan 28, 2020 10:41 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Direct Solar Subsidiary Secures Multiple Sales through Partnership with My Home Group

SinglePoint (OTCQB: SING) this morning announced that its Direct Solar America subsidiary has closed its initial set of sales through its partnership agreement with My Home Group Real Estate, LLC. The partnership enables more than 2,300 My Home Group agents to offer alternative energy options for homeowners that are interested in eco-conscious energy solutions. “We see this partnership being a major force for new business and increased solar systems installed throughout the U.S. through Direct Solar America. It is exciting to see the results start to come through after ironing out the process and being able to train My Home…

TuesdayJan 28, 2020 10:34 am

NetworkNewsBreaks – PharmaCielo Ltd. (TSX.V: PCLO) (OTCQX: PCLOF) Enters Pan-European Distribution Agreement for High-Grade CBD Isolate and Broad-Spectrum CBD Oil

PharmaCielo Ltd. (TSX.V: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced its entry into a three-year pan-European distribution agreement. Under the agreement, the Company's high-grade CBD isolate and broad-spectrum CBD oil will be sold to wholesalers and medicinal CPG product manufacturers through GMP certified lab owner, CBD Export Global. "The agreement with CBD Export Global is part of PharmaCielo's second-phase growth strategy complementing the first phase in which we established one of the largest cultivation and extraction operations in Colombia and initiated global sales, and now…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks